746 related articles for article (PubMed ID: 30894885)
1. Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
Hildegard Stancu S; Stanciu A; Lipan M; Capusa C
J Med Life; 2018; 11(4):293-298. PubMed ID: 30894885
[No Abstract] [Full Text] [Related]
2. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
3. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
4. Low 1,25-dihydroxyvitamin D level is associated with erythropoietin deficiency and endogenous erythropoietin resistance in patients with chronic kidney disease.
Kim IY; Kim JH; Kim MJ; Lee DW; Hwang CG; Han M; Rhee H; Song SH; Seong EY; Lee SB
Int Urol Nephrol; 2018 Dec; 50(12):2255-2260. PubMed ID: 30136086
[TBL] [Abstract][Full Text] [Related]
5. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.
Fujita Y; Doi Y; Hamano T; Hatazaki M; Umayahara Y; Isaka Y; Tsubakihara Y
Sci Rep; 2019 Oct; 9(1):14871. PubMed ID: 31619722
[TBL] [Abstract][Full Text] [Related]
6. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
Kim IY; Kim JH; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
[TBL] [Abstract][Full Text] [Related]
7. Anemia Prevalence, Type, and Associated Risks in a Cohort of 5.0 Million Insured Patients in the United States by Level of Kidney Function.
Farrington DK; Sang Y; Grams ME; Ballew SH; Dunning S; Stempniewicz N; Coresh J
Am J Kidney Dis; 2023 Feb; 81(2):201-209.e1. PubMed ID: 36181996
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A
Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
[TBL] [Abstract][Full Text] [Related]
9. Early response to erythropoiesis-stimulating agents in non-dialysis chronic kidney disease patients.
Kuwahara M; Arai Y; Takehara E; Sasaki Y; Yoshimine T; Kusaka K; Shikuma S; Akita W; Uchida S
Clin Exp Nephrol; 2016 Aug; 20(4):585-594. PubMed ID: 26511877
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, treatment status, and predictors of anemia and erythropoietin hyporesponsiveness in Japanese patients with non-dialysis-dependent chronic kidney disease: a cross-sectional study.
Tanaka S; Kitamura H; Tsuruya K; Kitazono T; Nakano T;
Clin Exp Nephrol; 2022 Sep; 26(9):867-879. PubMed ID: 35507237
[TBL] [Abstract][Full Text] [Related]
12. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
Milovanov YS; Mukhin NA; Kozlovskaya LV; Milovanova SY; Markina MM
Ter Arkh; 2016; 88(6):21-25. PubMed ID: 27296257
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietic Response to Anaemia of Dialysis Naïve Patients with Chronic Kidney Disease in Zaria, North-West Nigeria.
Dogara LG; Hassan A; Awwalu S; Okpetu L; Waziri AD; Babadoko AA; Bosan IB; Muktar HM
Niger J Clin Pract; 2018 Feb; 21(2):189-194. PubMed ID: 29465053
[TBL] [Abstract][Full Text] [Related]
14. Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics.
Minutolo R; Locatelli F; Gallieni M; Bonofiglio R; Fuiano G; Oldrizzi L; Conte G; De Nicola L; Mangione F; Esposito P; Dal Canton A;
Nephrol Dial Transplant; 2013 Dec; 28(12):3035-45. PubMed ID: 24145459
[TBL] [Abstract][Full Text] [Related]
15. A 3-marker index improves the identification of iron disorders in CKD anaemia.
Mercadal L; Metzger M; Haymann JP; Thervet E; Boffa JJ; Flamant M; Vrtovsnik F; Gauci C; Froissart M; Stengel B;
PLoS One; 2014; 9(2):e84144. PubMed ID: 24586229
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of anemia in predialysis chronic kidney disease patients.
Shaheen FA; Souqiyyeh MZ; Al-Attar BA; Karkar A; Al Jazairi AM; Badawi LS; Ballut OM; Hakami AH; Naguib M; Al-Homrany MA; Barhamein MY; Ahmed AM; Khardaji MM; Said SA;
Saudi J Kidney Dis Transpl; 2011 May; 22(3):456-63. PubMed ID: 21566300
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease.
Karava V; Dotis J; Kondou A; Christoforidis A; Taparkou A; Farmaki E; Economou M; Printza N
Pediatr Nephrol; 2023 Aug; 38(8):2771-2779. PubMed ID: 36862253
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of iron deficiency in predialysis state by low molecular weight iron dextran high doses intravenously].
Fievet P; Coppin M; Brazier F; Lefèvre M; Stephan R; Demontis R
Nephrol Ther; 2012 Feb; 8(1):41-6. PubMed ID: 21684231
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
